{"nctId":"NCT00309751","briefTitle":"Study Comparing Pitavastatin and Atorvastatin in Patients With Type II Diabetes Mellitus and Combined Dyslipidemia","startDateStruct":{"date":"2005-12"},"conditions":["Type II Diabetes Mellitus","Dyslipidemia"],"count":418,"armGroups":[{"label":"Pitavastatin 4 mg QD","type":"EXPERIMENTAL","interventionNames":["Drug: Pitavastatin"]},{"label":"Atorvastatin 20 mg QD","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Atorvastatin"]}],"interventions":[{"name":"Pitavastatin","otherNames":[]},{"name":"Atorvastatin","otherNames":["Lipitor"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Males and females (ages 18-75 years)\n* Type II DM treated with oral anti-diabetic medication (sulfonylurea, metformin, glitazones, or combination therapy)\n* Must have been following a restrictive diet\n* Diagnosis of combined dyslipidemia\n\nExclusion Criteria:\n\n* Homozygous familial hypercholesterolemia\n* Conditions which may cause secondary dyslipidemia\n* Uncontrolled diabetes mellitus\n* Abnormal pancreatic, liver, or renal function\n* Abnormal serum creatine kinase (CK) above the pre-specified level\n* Significant heart disease","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"75 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Percent Change From Baseline Low Density Lipoprotein Cholesterol (LDL-C)","description":"Percent change from baseline to Week 12 low density lipoprotein cholesterol (LDL-C)","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-40.78","spread":"19.599"},{"groupId":"OG001","value":"-43.25","spread":"16.378"}]}]}]},{"type":"SECONDARY","title":"Number of Patients Attaining National Cholesterol Education Program (NCEP) LDL-C Target","description":"Number of patients attaining National Cholesterol Education Program (NCEP)LDL-C target (LDL-C less than 160 mg/dL) at 12 weeks","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"212","spread":null},{"groupId":"OG001","value":"111","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":4},"commonTop":["Nasopharyngitis","Diarrhea","Myalgia","Hypertension"]}}}